Clinical Trials List
2022-07-01 - 2024-09-20
Phase III
Not yet recruiting3
Recruiting11
Terminated2
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李佳殷 無
- 李柏延 無
- Yi-Chun Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- W. C. LIN 無
- Hui-Chen Cheng 無
- T.P. SU 無
- 許志堅 無
- Ya-Mei Bai 無
- 鄭智銘 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林佩璇 未分科
- Tzu-Ting Chen 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 康祐銓 無
- Yih-Shiou Hwang 無
- 李晉邦 未分科
- Mao-Hsiu Hua 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Hui-Chen Cheng 無
- 林佳亨 無
- 林安省 無
- 潘亦蕾 無
- 許志堅 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 江國棟 未分科
- 許志堅 未分科
- Hui-Chen Cheng 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 江國棟 無
- Hui-Chen Cheng 無
- 葉柏寬 無
- 許志堅 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
250 participants
